Trials / Completed
CompletedNCT01952184
Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- Female
- Age
- 18 Years – 36 Years
- Healthy volunteers
- Accepted
Summary
The survival rate (and embryo quality) of donor oocytes with two commercially available devices.
Detailed description
Donor sibling oocytes will be vitrified with two commercially available devices. The first device is closed vitrification with closed storage and the second device is open vitrification with closed storage. Oocyte acceptors receive oocytes from both devices. With the increase in cooling rate generated by the open vitrification (second device), we expect to get an increase in survival rate of 10%. Besides this, embryo quality will be assessed with oocytes obtained from both devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CBSvit HS device | closed vitrification with closed storage |
| DEVICE | Cryotop SC device | open vitrification with closed storage |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2013-09-27
- Last updated
- 2015-12-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01952184. Inclusion in this directory is not an endorsement.